{"filing":{"accession_number":"0001193125-26-269377","cik":"0001774857","ticker":"AARD","company_name":"Aardvark Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"ck0001774857-20260610.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1774857/000119312526269377/ck0001774857-20260610.htm"},"events":[{"id":10786,"run_id":9463,"accession_number":"0001193125-26-269377","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses retention bonus letter agreements entered into on June 10, 2026 with two named executives: Nelson Sun (CFO/COO) receiving $346,500 and Dr. Manasi Jaiman (CMO) receiving $357,000. These are compensatory arrangements—guaranteed annual bonuses and retention bonuses—payable contingent on continued employment or qualifying termination events, which is the hallmark of exec_compensation disclosures under Item 5.02(e).","company_name":"Aardvark Therapeutics, Inc.","ticker":"AARD","filing_date":"2026-06-12","submitted_at":null,"items":[{"id":7185,"accession_number":"0001193125-26-269377","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses retention bonus letter agreements entered into on June 10, 2026 with two named executives: Nelson Sun (CFO/COO) receiving $346,500 and Dr. Manasi Jaiman (CMO) receiving $357,000. These are compensatory arrangements—guaranteed annual bonuses and retention bonuses—payable contingent on continued employment or qualifying termination events, which is the hallmark of exec_compensation disclosures under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:17:36.803869+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7185,"accession_number":"0001193125-26-269377","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses retention bonus letter agreements entered into on June 10, 2026 with two named executives: Nelson Sun (CFO/COO) receiving $346,500 and Dr. Manasi Jaiman (CMO) receiving $357,000. These are compensatory arrangements—guaranteed annual bonuses and retention bonuses—payable contingent on continued employment or qualifying termination events, which is the hallmark of exec_compensation disclosures under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:17:36.803869+00:00","company_name":"Aardvark Therapeutics, Inc.","ticker":"AARD","filing_date":"2026-06-12"}]}